Cross-talks via mTORC2 can explain enhanced activation in response to insulin in diabetic patients

The molecular mechanisms of insulin resistance in Type 2 diabetes have been extensively studied in primary human adipocytes, and mathematical modelling has clarified the central role of attenuation of mammalian target of rapamycin (mTOR) complex 1 (mTORC1) activity in the diabetic state. Attenuation of mTORC1 in diabetes quells insulin-signalling network-wide, except for the mTOR in complex 2 (mTORC2)-catalysed phosphorylation of protein kinase B (PKB) at Ser473 (PKB-S473P), which is increased. This unique increase could potentially be explained by feedback and interbranch cross-talk signals. To examine if such mechanisms operate in adipocytes, we herein analysed data from an unbiased phosphoproteomic screen in 3T3-L1 adipocytes. Using a mathematical modelling approach, we showed that a negative signal from mTORC1-p70 S6 kinase (S6K) to rictor–mTORC2 in combination with a positive signal from PKB to SIN1–mTORC2 are compatible with the experimental data. This combined cross-branch signalling predicted an increased PKB-S473P in response to attenuation of mTORC1 – a distinguishing feature of the insulin resistant state in human adipocytes. This aspect of insulin signalling was then verified for our comprehensive model of insulin signalling in human adipocytes. Introduction of the cross-branch signals was compatible with all data for insulin signalling in human adipocytes, and the resulting model can explain all data network-wide, including the increased PKB-S473P in the diabetic state. Our approach was to first identify potential mechanisms in data from a phosphoproteomic screen in a cell line, and then verify such mechanisms in primary human cells, which demonstrates how an unbiased approach can support a direct knowledge-based study.

[1]  B. Manning Comment on “A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation”: Building a Model of the mTOR Signaling Network with a Potentially Faulty Tool , 2012, Science Signaling.

[2]  G. Thomas,et al.  ReviewNutrient overload , insulin resistance , and ribosomal protein S 6 kinase 1 , S 6 K 1 , 2022 .

[3]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[4]  R. Hresko,et al.  mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.

[5]  Mee-Sup Yoon,et al.  The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance , 2016, Experimental & Molecular Medicine.

[6]  G. Thomas,et al.  Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.

[7]  Robert Tjian,et al.  Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. , 2005, Genes & development.

[8]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[9]  David E James,et al.  A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. , 2015, Cell reports.

[10]  Claudio Franceschi,et al.  Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[11]  A. Marette,et al.  Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. , 2005, Endocrinology.

[12]  Gunnar Cedersund,et al.  A Single Mechanism Can Explain Network-wide Insulin Resistance in Adipocytes from Obese Patients with Type 2 Diabetes* , 2014, The Journal of Biological Chemistry.

[13]  G. Cedersund,et al.  Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes* , 2016, The Journal of Biological Chemistry.

[14]  J. Downward,et al.  Rictor is a novel target of p70 S6 kinase-1 , 2010, Oncogene.

[15]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[16]  P. Strålfors,et al.  Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes* , 2005, Journal of Biological Chemistry.

[17]  Steven P. Gygi,et al.  Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signaling to suppress tumorigenesis , 2013, Nature Cell Biology.

[18]  Gunnar Cedersund,et al.  Insulin Signaling in Type 2 Diabetes , 2013, The Journal of Biological Chemistry.

[19]  David E. James,et al.  Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes* , 2011, The Journal of Biological Chemistry.

[20]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[21]  Wenyi Wei,et al.  Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity , 2014, Protein & Cell.

[22]  G. Cedersund,et al.  Insulin signaling – mathematical modeling comes of age , 2012, Trends in Endocrinology & Metabolism.

[23]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[24]  V. Kiselyov,et al.  Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation , 2009, Molecular systems biology.

[25]  G. Franck Open access , 2012, Cell cycle.

[26]  P. Strålfors,et al.  Attenuated mTOR Signaling and Enhanced Autophagy in Adipocytes from Obese Patients with Type 2 Diabetes , 2010, Molecular medicine.

[27]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[28]  Philippe P Roux,et al.  mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling , 2009, Molecular and Cellular Biology.

[29]  Henning Schmidt SBaddon: high performance simulation for the Systems Biology Toolbox for MATLAB , 2007, Bioinform..

[30]  Gunnar Cedersund,et al.  A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis* , 2011, The Journal of Biological Chemistry.

[31]  M. White,et al.  Irs1 serine 307 promotes insulin sensitivity in mice. , 2010, Cell metabolism.

[32]  P. Strålfors,et al.  Short-Term Overeating Induces Insulin Resistance in Fat Cells in Lean Human Subjects , 2009, Molecular medicine.

[33]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[34]  David E. James,et al.  Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2 , 2013, Cell metabolism.

[35]  K. Petersen,et al.  Insulin Resistance in Type 2 Diabetes , 2016 .

[36]  Maria J. Pereira,et al.  mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes , 2012, Molecular and Cellular Endocrinology.

[37]  Gunnar Cedersund,et al.  Mechanistic explanations for counter‐intuitive phosphorylation dynamics of the insulin receptor and insulin receptor substrate‐1 in response to insulin in murine adipocytes , 2012, The FEBS journal.

[38]  Natal A W van Riel,et al.  Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes , 2016, Interface Focus.

[39]  Gunnar Cedersund,et al.  Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework* , 2010, The Journal of Biological Chemistry.

[40]  J. Olefsky Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. , 1976, The Journal of clinical investigation.

[41]  J. Asara,et al.  Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.

[42]  H. Tanak,et al.  Density functional computational studies on (E)-2-[(2-Hydroxy-5-nitrophenyl)-iminiomethyl]-4-nitrophenolate , 2010, Journal of molecular modeling.